Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials.
BMC Cancer
; 21(1): 1083, 2021 Oct 07.
Article
in En
| MEDLINE
| ID: mdl-34620124
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Quality of Life
/
Severity of Illness Index
/
Health Surveys
/
Diarrhea
/
Clinical Deterioration
Type of study:
Prognostic_studies
Limits:
Aged
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2021
Type:
Article
Affiliation country:
Austria